Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study

Blood Cancer Journal, Published online: 24 March 2023; doi:10.1038/s41408-023-00816-8Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study

Source: Blood Cancer Journal - March 24, 2023 Category: Hematology Authors: Fen Saj Yadav Nisha Prasanth Ganesan Smita Kayal Rakhee Kar Dhanapathi Halanaik Biswajit Dubashi Source Type: research